Gareth Sheridan, CEO of Nutriband Inc. (NASDAQ: NTRB), has been named a finalist in the Established category of the 2025 EY Entrepreneur of the Year Awards. Sheridan is one of 27 Irish entrepreneurs selected from 24 companies generating over €1 billion in annual revenue.
The recognition comes in response to Sheridan's leadership in transforming Nutriband from an early-stage startup to a publicly listed life sciences company specializing in transdermal drug delivery and abuse-deterrent technologies. The company's flagship product, AVERSA™, is designed to prevent misuse and abuse of opioid patches, addressing a critical challenge in pain management.
As a finalist, Sheridan will participate in a CEO retreat in Japan and compete for the overall Entrepreneur of the Year title, which will be awarded at a gala event in November. This recognition underscores the company's innovative approach to solving complex healthcare challenges and potential for continued growth in the pharmaceutical technology sector.
